Top 6 Companies in the Global Endometrial Ablation Market in 2025

The global endometrial ablation market is expected to grow at a CAGR of 7.30% during the forecast period of 2025-2034, driven by the rising incidence of gynecological disorders along with the growing preference for minimally invasive procedures across the globe.

Endometrial ablation is a minimally invasive surgical procedure that is used in the treatment of abnormal uterine bleeding. In this method, heat, cold, or any other type of energy is utilized to destroy the endometrial lining of the uterine cavity. Compared to hysterectomy, endometrial ablation can be performed quickly in an outpatient patient. It is also relatively painless and requires a shorter recovery period.

The rising incidence of gynecological conditions such as abnormal uterine bleeding (AUB) is contributing to the increasing demand for endometrial ablation procedures. It is estimated that abnormal uterine bleeding is experienced by up to one-third of women in their life. Such irregularities are typically prominent during menarche and perimenopause and a higher incidence of abnormal uterine bleeding is reported in this phase. Women experiencing heavy menstrual bleeding are increasingly preferring minimally invasive gynecologic surgical options such as endometrial ablation, thereby boosting the market growth.
 
A significant market trend is the increasing improvements in endometrial ablation devices which is likely to elevate the market value in coming years. Recent technological advancements such as the development of next-generation radiofrequency, thermal balloon, and cryoablation devices are anticipated to fuel the adoption of endometrial ablation. Further, the growing focus on women's reproductive health is poised to aid in the market expansion.

The market is also experiencing significant growth in emerging economies, such as the Asia Pacific and Latin America, propelled by increasing healthcare expenditure, substantial investments in healthcare infrastructure, and rising awareness regarding women’s health issues. Several leading market players are expanding their presence in these regions by establishing manufacturing facilities and forming strategic partnerships with local distributors.

Top Companies Leading the Global Endometrial Ablation Market in 2025

1. Boston Scientific Corporation

This multinational manufacturer of medical devices is headquartered in Marlborough, Massachusetts, and enjoys a prominent presence in the market. Boston Scientific's next-generation endometrial ablation system called Genesys HTA™ System is cleared by the U.S. Food and Drug Administration (FDA) to destroy the endometrial lining of the uterus in premenopausal women suffering from menorrhagia. The company continues to expand its market presence through strategic acquisitions and partnerships as well as by integrating advanced imaging technologies.

2. CooperSurgical, Inc.

CooperSurgical, Inc., a leading player in the women's healthcare market, is known for its fertility and genomic products and manufacturing medical devices. The company is focused on developing minimally invasive devices that are linked with quick recovery times and suitability to outpatient settings. In February 2021, CooperSurgical made a major acquisition deal, acquiring AEGEA Medical and gaining access to its FDA-approved Mara™ Water Vapor Ablation System. This endometrial ablation treatment relies on water vapor to treat heavy menstrual bleeding and is an in-office procedure that can be performed in 2 minutes to ablate the lining of the uterus.

3. Hologic, Inc.

Hologic, Inc., headquartered in Massachusetts, United States, is a global medical technology company innovating in the field of women's health. Hologic is known for developing, manufacturing, and distributing diagnostic and surgical products, and medical imaging systems. Hologic’s NovaSure is the key product of the company and is considered one of the most widely used endometrial ablation systems due to its effectiveness and minimally invasive nature. It is estimated that 3 million patients have benefitted from NovaSure globally. In February 2023, the NovaSure® V5 global endometrial ablation (GEA) device, an innovative NovaSure version with updated features, received regulatory approval in Canada and Europe.

4. IDOMAN-MED

This privately owned medical device company has offices and manufacturing units located in the west of Ireland and Toronto, Ontario, Canada. Idoman specializes in the development of minimally invasive gynecological products to improve the quality of life of women. Its product Thermoblate EAS is used for treating heavy bleeding and has been utilised in 30 countries. IDOMAN-MED is actively engaged in boosting its market presence through strategic partnerships and distribution agreements in various regions.

5. Minerva Surgical, Inc.

Minerva Surgical, Inc. is one of the significant companies in the market, known for developing medical devices that cater to women's healthcare needs. The company leverages strategic partnerships to strengthen its market position (such as its acquisition of Boston Scientific's Intrauterine Health franchise in 2020) and is focused on regulatory approvals in new markets. Its leading asset Minerva ES Endometrial Ablation System has integrated PlasmaSense technology to deliver consistent depth of ablation in 120 seconds. 

6. Medtronic

This American-Irish medical device company has a strong presence in the market, leveraging its expertise in medical devices to develop ablation systems for the treatment of abnormal uterine bleeding. Some of its key products include the Emprint™ ablation systems with Thermosphere™ technology and the Cool-tip™ radiofrequency ablation systems. Medtronic heavily invests in research and development to advance its endometrial ablation technologies, with emphasis on improving the safety and efficacy of its devices. The company boasts a robust distribution network, ensuring that its endometrial ablation products are easily available in different regions, including North America, Europe, Asia Pacific, and Latin America.